QSS
MRSN

Quantitative Systematic Strategies’s Mersana Therapeutics MRSN Stock Holding History

Quantitative Systematic Strategies’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-527
Closed -$213K – 584
2021
Q1 		$213K Sell
527
-160
-23% -$77.6K 0.03% 550
2020
Q4 		$457K Sell
687
-397
-37% -$221K 0.06% 406
2020
Q3 		$505K Buy
1,084
+261
+32% +$132K 0.09% 321
2020
Q2 		$481K Sell
823
-941
-53% -$321K 0.1% 317
2020
Q1 		$257K Buy
1,764
+916
+108% +$160K 0.21% 171
2019
Q4 		$121K Buy
+848
New +$62K 0.02% 518
2018
Q2 		– Sell
-687
Closed -$271K – 723
2018
Q1 		$271K Buy
+687
New +$271K 0.06% 481

Other funds holding MRSN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Quantitative Systematic Strategies's MRSN Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Mersana Therapeutics (MRSN) in Q2 2021, closing a stake of 527 shares — an estimated $213K sold.

Quantitative Systematic Strategies first reported a position in MRSN in Q1 2018 and held it in 7 quarters. The position peaked at $505K in Q3 2020. 131 funds tracked by Wall St. Rank hold MRSN as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Mersana Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 527 Mersana Therapeutics shares in Q2 2021, an estimated $213K.
  • Quantitative Systematic Strategies first reported a position in Mersana Therapeutics in Q1 2018 and held it in 7 quarters.
  • Quantitative Systematic Strategies's Mersana Therapeutics position peaked at $505K in Q3 2020.
  • 131 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.